Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Your RPS 

NICE accredits RPS process for developing professional standards and guidance

The National Institute for Health and Care Excellence (NICE), the health technology assessment body that provides guidance on which drugs should be used on the NHS in England, has accredited the process used by the Royal Pharmaceutical Society (RPS) to develop its professional standards and guidance.

The NICE badge will be applied retrospectively to standards and guidance developed by the RPS using the accredited process. 

The accreditation, which is valid for five years, now covers the ‘RPS Competency Framework for all Prescribers’, which aims to “help healthcare professionals to be safe, effective prescribers”.

The framework was originally developed by the National Prescribing Centre and published by NICE in 2012, and then updated by the RPS in 2015–2016. It is now maintained and published by the RPS on behalf of, and in collaboration with, all prescribing professions in the UK.

Standards and guidance still being developed will also be accredited, as will revisions or updates to existing documents.

Commenting on the NICE accreditation, Alex MacKinnon, interim chief executive of the RPS, says: “We are delighted that we have achieved NICE accreditation of our processes for developing professional standards and guidance.

“It involves a rigorous application process and so achieving recognition is a substantial achievement. Our processes align to those of other royal colleges and this demonstrates that the RPS are developing standards and guidance to the highest standards.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202574

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Alex MacKinnon, interim chief executive of the RPS

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.